NR-23_Burkholderiamallei,中国7(NBL7)(细菌)
产品图片
货号/SKU
NR-23
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、3
产品描述信息
NR-23??Burkholderia mallei, China 7 (NBL 7) (Bacteria)|Burkholderia mallei|China 7 (NBL 7) ||ATCC?Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Burkholderia mallei, Strain China 7 (NBL 7), NR-23."| Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Burkholderia mallei (B. mallei), strain China 7 (NBL 7) was isolated from postmortem cultures of knee fluid, skin pustules, and blood of a Chinese soldier who died in Burma in 1944 from a glanders-melioidosis type of infection. B. mallei, strain China 7 (NBL 7) was deposited to the ATCC ? in 1967 by George A. Hottle of the Naval Biological Laboratory, University of California at Berkeley and accessioned as ATCC ? 23344?. NR-23 was produced directly from a lot of ATCC ? 23344?.
Genome variability upon passage has been reported to be a feature of B. mallei, strain China 7. Two other preparations of B. mallei, strain China 7 are available from BEI Resources. NR-4071 was derived from a lot of ATCC ? 23344? via several passages by different individuals prior to deposit to BEI Resources. NR-36128 was accessioned by the National Collection of Type Cultures (NCTC) in 2007 and deposited to BEI Resources by the Health Protection Agency, United Kingdom (Public Health England). The passage history of the NCTC version of strain China 7 is not known. The complete genome sequence from a preparation of B. mallei, strain China 7 is available (GenBank: CP000010 and CP000011).
Each vial contains approximately 1 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Burkholderia mallei (B. mallei), strain China 7 (NBL 7) was isolated from postmortem cultures of knee fluid, skin pustules, and blood of a Chinese soldier who died in Burma in 1944 from a glanders-melioidosis type of infection. B. mallei, strain China 7 (NBL 7) was deposited to the ATCC ? in 1967 by George A. Hottle of the Naval Biological Laboratory, University of California at Berkeley and accessioned as ATCC ? 23344?. NR-23 was produced directly from a lot of ATCC ? 23344?.
Genome variability upon passage has been reported to be a feature of B. mallei, strain China 7. Two other preparations of B. mallei, strain China 7 are available from BEI Resources. NR-4071 was derived from a lot of ATCC ? 23344? via several passages by different individuals prior to deposit to BEI Resources. NR-36128 was accessioned by the National Collection of Type Cultures (NCTC) in 2007 and deposited to BEI Resources by the Health Protection Agency, United Kingdom (Public Health England). The passage history of the NCTC version of strain China 7 is not known. The complete genome sequence from a preparation of B. mallei, strain China 7 is available (GenBank: CP000010 and CP000011).
Each vial contains approximately 1 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送至NIAID进行批准. Burkholderia Mallei(B.Mallei),菌株中国7(NBL 7)与膝关节,皮脓疱和中国士兵血液的后期培养物分离谁在1944年在缅甸丧生,从腺体 - 融合型感染类型. b. Mallei ,应变中国7(NBL 7)于1967年被乔治A.伯爵A.伯克利大学海军A.热电厂沉积到ATCC ?. >? 23344?. NR-23直接由大量的ATCC ? 23344?生产. 据报道,基因组可变性是 b的特征. Mallei ,菌株中国7.另外两种制剂 b. Mallei ,菌株中国7可从Bei资源获得.在沉积到BEI资源之前,NR-4071通过不同个体的几个通道来源于大量ATCC ? 23344?. NR-36128由2007年全国型文化收集(NCTC)加入,并由英国卫生保护局(公共卫生英国)的北极资源存入. NCTC Rucky Thina 7的段落历史尚不清楚.来自制备 B的完整基因组序列. Mallei ,Train China 7可用(Genbank: cp000010 和 cp000011 ). patric (Pathosystems资源集成中心)提供了附加信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2024-01-21
2022-03-31
2021-12-02
2022-04-01
2020-08-04
2022-04-01
2021-12-02
2022-04-01
2021-12-21